Free Trial

Cellebrite DI (CLBT) Stock Price, News & Analysis

-0.01 (-0.08%)
(As of 07/19/2024 ET)
Today's Range
50-Day Range
52-Week Range
633,627 shs
Average Volume
1.52 million shs
Market Capitalization
$2.58 billion
P/E Ratio
Dividend Yield
Price Target

Cellebrite DI MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
4.9% Upside
$13.17 Price Target
Short Interest
3.39% of Float Sold Short
Dividend Strength
News Sentiment
0.66mentions of Cellebrite DI in the last 14 days
Based on 8 Articles This Week
Insider Trading
Proj. Earnings Growth
From $0.34 to $0.42 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.39 out of 5 stars

Business Services Sector

222nd out of 296 stocks

Prepackaged Software Industry

158th out of 193 stocks

CLBT stock logo

About Cellebrite DI Stock (NASDAQ:CLBT)

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.

CLBT Stock Price History

CLBT Stock News Headlines

This student turned $1,300 into $45,000 in just 4 Months!
With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.
This student turned $1,300 into $45,000 in just 4 Months!
With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.
Cellebrite DI Ltd. (CLBTW)
Cellebrite Announces First-Quarter 2024 Results
Cellebrite Q1 2024 Earnings Preview
See More Headlines
Receive CLBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellebrite DI and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Confirmed)
Fiscal Year End

Industry, Sector and Symbol

Prepackaged software
Computer Software
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
6 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$325.11 million
Cash Flow
$0.27 per share
Book Value
$0.18 per share


Free Float
Market Cap
$2.58 billion
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Yossi Carmil (Age 56)
    Founder, CEO & Director
    Comp: $1.14M
  • Ms. Dana Gerner (Age 57)
    Chief Financial Officer
    Comp: $649k
  • Mr. Ronnen Armon (Age 61)
    Chief Products & Technologies Officer
    Comp: $516k
  • Ms. Lisa Cole (Age 49)
    Chief Marketing Officer
    Comp: $499k
  • Mr. Leeor Ben-Peretz (Age 48)
    Chief Strategy Officer
    Comp: $470k
  • Mr. Thomas E. Hogan (Age 65)
    Executive Chairman
  • Mr. Arnon Zilberman
    Executive Vice President of Information Systems & Operations
  • Andrew Kramer
    Vice President of Investor Relations
  • Ms. Ayala Berler Shapira (Age 53)
    General Counsel & Chief Compliance Officer
  • Ms. Zohar Tadmor-Eilat (Age 53)
    Chief People Officer

CLBT Stock Analysis - Frequently Asked Questions

How have CLBT shares performed this year?

Cellebrite DI's stock was trading at $8.66 at the beginning of the year. Since then, CLBT shares have increased by 44.9% and is now trading at $12.55.
View the best growth stocks for 2024 here

How were Cellebrite DI's earnings last quarter?

Cellebrite DI Ltd. (NASDAQ:CLBT) released its quarterly earnings data on Thursday, May, 23rd. The company reported $0.08 EPS for the quarter, topping analysts' consensus estimates of $0.06 by $0.02. The company's quarterly revenue was up 25.8% on a year-over-year basis.

Who are Cellebrite DI's major shareholders?

Cellebrite DI's top institutional shareholders include Harbor Capital Advisors Inc. (0.02%) and Juncture Wealth Strategies LLC (0.02%).

How do I buy shares of Cellebrite DI?

Shares of CLBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CLBT) was last updated on 7/21/2024 by Staff

From Our Partners